[ad_1] Pear Therapeutics has announced the availability of Somryst, the only digital therapy for chronic insomnia authorized by the US Food and Drug Administration to date. (To read Psychiatric TimesTM previous coverage of Somryst and watch a video with Yuri Maricich, MD, chief medical officer of Pear Therapeutics.) “We are …
Read More »A new digital therapy for chronic insomnia
